ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $228 | -95.4% | 10,927 | -94.7% | 0.00% | -90.9% |
| Q2 2023 | $4,950 | -1.4% | 206,656 | -22.5% | 0.01% | -8.3% |
| Q1 2023 | $5,018 | +283.6% | 266,644 | +224.6% | 0.01% | +300.0% |
| Q4 2022 | $1,308 | -100.0% | 82,139 | -51.5% | 0.00% | -62.5% |
| Q3 2022 | $2,773,000 | -65.9% | 169,506 | -51.3% | 0.01% | -50.0% |
| Q4 2021 | $8,125,000 | -31.2% | 348,107 | -51.1% | 0.02% | -33.3% |
| Q3 2021 | $11,812,000 | -32.9% | 711,167 | -1.4% | 0.02% | -33.3% |
| Q2 2021 | $17,599,000 | -23.1% | 721,546 | -18.6% | 0.04% | -28.0% |
| Q1 2021 | $22,882,000 | -45.8% | 886,913 | +12.3% | 0.05% | -49.0% |
| Q4 2020 | $42,237,000 | +32.1% | 790,077 | +1.9% | 0.10% | +15.3% |
| Q3 2020 | $31,975,000 | – | 775,152 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |